GRMN
58
2
EQR
40
-4
KIM
61
-2
EXR
51
-6
QCOM
60
-2
NEM
53
-2
DAL
80
3
MA
72
-2
ORLY
47
-2
MKC
57
-6
FOXA
74
5
COST
47
-4
JNJ
53
-4
NI
68
-4
FIS
60
-3
ADT
89
3
FLS
71
2
MTCH
46
6
FSLR
78
24
CB
51
-6
GRMN
58
2
EQR
40
-4
KIM
61
-2
EXR
51
-6
QCOM
60
-2
NEM
53
-2
DAL
80
3
MA
72
-2
ORLY
47
-2
MKC
57
-6
FOXA
74
5
COST
47
-4
JNJ
53
-4
NI
68
-4
FIS
60
-3
ADT
89
3
FLS
71
2
MTCH
46
6
FSLR
78
24
CB
51
-6
Financhill
Back

Regions Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
77

RF
Regions Financial

Last Price:
$22.46
Seasonality Move:
0.76%
Sell
42

SRPT
Sarepta Therapeutics

Last Price:
$36.18
Seasonality Move:
13.8%
Buy
77
Regions Financial (RF) is a Buy

Is Regions Financial a Buy, Sell or Hold?

  • The current Regions Financial [RF] share price is $22.44. The Score for RF is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • RF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $36.20. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RF Stock Price Chart

What is Regions Financial's stock price today?

  • The Regions Financial share price today is $22.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RF is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $36.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

RF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 66.88 Buy
Chaikin Money Flow: 3253851 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.24 - 21.24) Buy
Bollinger Bands (100): (20.6 - 24.34) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.97 Sell
Relative Strength Index (14 RSI): 22.77 Sell
Chaikin Money Flow: 421748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.5 - 62.32) Sell
Bollinger Bands (100): (63.01 - 120.77) Sell

RF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.35 Buy
20-day SMA: 20.52 Buy
50-day SMA: 20.85 Buy
200-day SMA: 23.02 Sell
8-day EMA: 21.46 Buy
20-day EMA: 20.9 Buy
50-day EMA: 21.19 Buy
200-day EMA: 22.12 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.5 Sell
20-day SMA: 53.1 Sell
50-day SMA: 67.21 Sell
200-day SMA: 110.18 Sell
8-day EMA: 42.66 Sell
20-day EMA: 50.94 Sell
50-day EMA: 65.94 Sell
200-day EMA: 99.51 Sell

Regions Financial Earnings Growth & RF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.14 per share, and an increase next year of $0.20 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.87 per share, a decrease this year of $3.97 per share, and an increase next year of $8.43 per share.

Regions Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):